Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Aaron Parry

Obstetrics Charleston, WV Medical Doctor

NPI 1982864799 CMS profile 226354

830 Pennsylvania Ave, Suite 301, Charleston, WV 25302

Open in the dashboard

General payments

$165,410

556 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$2

2 holdings reported · through program year 2025

Through program year 2025, Aaron Parry of Charleston, WV is reported in the CMS Open Payments database as having received $165,410 across 556 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $2 across 2 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Obstetrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,584 77
2024 General $4,836 46
2023 General $8,765 81
2022 General $17,369 73
2021 General $69,684 125
2020 General $20,638 49
2019 General $42,534 105
2024 Ownership $1 1
2023 Ownership $1 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Aaron Parry
  • Obstetrics median
  • Middle half of Obstetrics
  • National median

In program year 2025, general payments to Aaron Parry were reported at $1,584. Among 649 Obstetrics profiles paid that year, the median was $181 and the middle half received between $61 and $424.

Show as a table
Year Aaron Parry Obstetrics median Middle half National median
2019 $42,534 $177 $60–$381 $163
2020 $20,638 $92 $35–$201 $114
2021 $69,684 $125 $40–$351 $132
2022 $17,369 $186 $65–$448 $149
2023 $8,765 $183 $61–$451 $160
2024 $4,836 $176 $62–$406 $164
2025 $1,584 $181 $61–$424 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $154,886 270 payments
  2. Acessa Health Inc. $3,813 3 payments
  3. Intuitive Surgical, Inc. $1,127 7 payments
  4. Mayne Pharma Inc. $830 43 payments
  5. Shield Therapeutics Inc $521 25 payments
  6. Bayer HealthCare Pharmaceuticals Inc. $427 21 payments
  7. Hologic, LLC $396 14 payments
  8. Astellas Pharma US Inc $369 13 payments
  9. Exeltis, USA Inc. $301 17 payments
  10. Sumitomo Pharma America, Inc. $288 11 payments
  11. Other $2,454 132 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $122,975 74 payments
  2. Travel and Lodging $21,301 58 payments
  3. Consulting Fee $11,163 5 payments
  4. Food and Beverage $9,762 409 payments
  5. Education $210 10 payments
Products named General payments · program years 2019–2025
  1. ORILISSA Womens Health $72,122 119 payments
  2. ORIAHNN $70,896 90 payments
  3. Orilissa Endocrinology $36,442 67 payments
  4. ACESSA PROVU SYSTEM $4,000 7 payments
  5. Da Vinci Surgical System $880 5 payments
  6. LO LOESTRIN FE $551 44 payments
  7. ACCRUFER $521 25 payments
  8. LILETTA $321 22 payments
  9. DA VINCI SP $247 2 payments
  10. ZURZUVAE $227 8 payments
  11. Other $5,145 302 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 16 billing codes

Paid by Medicare

$7,504

Medicare's payments for the services billed

Medicare patients

67

Average age 70

Services billed

125

67 women, 0 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 61%
Arthritis 46%
Diabetes 27%
Osteoporosis 21%
Ischemic heart disease 19%
Chronic kidney disease 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 10 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
NEXTSTELLIS
  • Mayne Pharma Inc. $117
$117 — —
Veozah
  • Astellas Pharma US Inc $55
$55 — —
MYFEMBREE
  • Sumitomo Pharma America, Inc. $49
$49 — —
INJECTAFER
  • Daiichi Sankyo Inc. $28
$28 — —
SLYND
  • Exeltis, USA Inc. $22
$22 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 10 in the dashboard with a free account

Records

556 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Obstetrics in West Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record